Draw/line
Education and research purposes only, not medical advice. Unapproved compounds are not for human consumption. Check every result with your prescriber. Disclaimer Research and education only. Not medical advice. Disclaimer
Home / Compounds / Tadalafil

Tadalafil

Tadalafil (Cialis, Adcirca): approved uses for ED, BPH and PAH, the 48-hour nitrate rule, label warnings and hidden tadalafil in supplements.

FDA-approved, prescription only · Evidence grade A · Reviewed

Approved and studied uses
  • FDA-approvedErectile dysfunctionCialis
  • FDA-approvedEnlarged prostateCialis
  • FDA-approvedPulmonary arterial hypertensionAdcirca

Tadalafil (Cialis, Adcirca). PDE5 inhibitor.

AFDA-approved, prescription only. Evidence grade A: approved, large human trials.

What is Tadalafil?

Tadalafil is a long-acting PDE5 blocker that relaxes smooth muscle in blood vessels and the prostate. It treats erectile dysfunction, an enlarged prostate and pulmonary arterial hypertension (PAH).

Is Tadalafil FDA-approved?

Cialis was first approved in 2003 for erectile dysfunction. In 2011 FDA added benign prostatic hyperplasia (BPH) and combined ED and BPH. Adcirca was approved in 2009 for PAH (WHO Group 1). Cialis is still listed as prescription only. FDA has found hidden tadalafil in many products sold as sexual enhancement supplements.

What does the evidence show for Tadalafil?

Approval rests on randomized, placebo-controlled trials, including a 16-week trial in 405 people with PAH, and two decades of use.

What are the known risks of Tadalafil?

Tadalafil must not be used with nitrates. If a nitrate is needed in an emergency, the label says at least 48 hours should pass after the last tadalafil dose. It must not be used with guanylate cyclase stimulators such as riociguat. The label warns of sudden vision loss (NAION), sudden hearing loss, priapism, low blood pressure with alpha-blockers, and higher drug levels with strong CYP3A4 inhibitors. Tadalafil is not on the 2026 WADA Prohibited List.

How is Tadalafil measured?

A tablet, so there is nothing to draw or calculate.

Sources: FDA label: Cialis (tadalafil) tablets, 2018; FDA label: Cialis with BPH indications, 2011; FDA label: Adcirca (tadalafil), 2020; FDA: NUX Male Enhancement contains hidden sildenafil and tadalafil; WADA: 2026 Prohibited List. This profile does not recommend any dose or use.

For research and educational use. Not medical advice. Regulatory status changes, so confirm the current position with FDA or a licensed professional.

Spot a mistake or an out-of-date fact? Report an error. We check every report against the sources.